803
Participants
Start Date
January 31, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
June 30, 2009
Alogliptin
Alogliptin tablets.
Pioglitazone
Pioglitazone tablets.
Metformin
Metformin HCl tablets (immediate-release, commercially available formulation) ≥1500 mg or maximum tolerated dose.
Placebo
Matching placebo tablets.
Birmingham
Huntsville
Lake Havasu City
Little Rock
Foothill Ranch
Los Alamitos
Los Angeles
Pismo Beach
San Diego
Golden
Clearwater
Hialeah
Lakeland
Marianna
Miami
North Miami Beach
Pembroke Pines
Sebastian
South Miami
Tampa
Winter Park
Blue Ridge
Conyers
Decatur
Duluth
Dunwoody
Warner Robins
Boise
Coeur d'Alene
Burr Ridge
Chicago
Melrose Park
Naperville
O'Fallon
Bloomington
Mishawaka
Overland Park
Marrero
Elkton
Rockville
Towson
Marlborough
Bay City
Saint Clair Shores
McCook
Las Vegas
Blackwood
Trenton
West Caldwell
Asheboro
Charlotte
Mooresville
Shelby
Sparta
Bismarck
Orrville
Norman
Ashland
Aliquippa
Altoona
Dawningtown
Fleetwood
Kingston
Norristown
Pittsburgh
Tipton
Florence
Taylors
Williamston
Watertown
Kingsport
Milan
Nashville
Arlington
Austin
Colleyville
El Paso
Garland
Houston
Hurst
San Antonio
Seguin
Hampton
Norfolk
Richmond
Virginia Beach
Lead Sponsor
Takeda
INDUSTRY